PF-614

N/A

Report date: 2024/09/20 20:00:41

Base Information

Drug NamePF-614
Drug Alias NamePRODRUG OF OXYCODONEER Oxycodone(Ensysce Biosciences)Oxycodone prodrug extended release(Ensysce Biosciences)BIO-MDPF614-MPAR™ +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor agonistsOpioid receptors agonists
TargetsOpioid receptorsMu opioid receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsAcute PainPain +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnsysce Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnsysce Biosciences Inc
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse ReactionsAcute PainPain +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A